IVD Raw Materials Global Market Report 2025

The IVD raw materials market size has grown rapidly in recent years. It will grow from $25.13 billion in 2024 to $27.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period can be attributed to the increasing prevalence of infectious and chronic diseases, a rising demand for laboratory-based diagnostic testing, a greater use of enzyme- and protein-based reagents in diagnostics, the expansion of clinical diagnostic laboratories, and heightened awareness and efforts for early disease detection.

The IVD raw materials market size is expected to see rapid growth in the next few years. It will grow to $40.74 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated in the forecast period is driven by the growing demand for high-sensitivity and rapid diagnostic solutions, the expanding use of molecular diagnostics in oncology, the rising geriatric population and its associated disease burden, the increasing need for companion diagnostics, and growing investments from biopharmaceutical companies. Key trends expected in the forecast period include a shift towards recombinant and synthetic raw materials, the integration of multiplex assays that require specialized materials, the adoption of lyophilized and ready-to-use reagent formats, and the development of raw materials designed for microfluidic and lab-on-a-chip systems.

The increasing prevalence of infectious diseases is expected to drive the growth of the IVD raw materials market. Infectious diseases are caused by harmful microorganisms that can spread between individuals or organisms. The growing prevalence of these diseases is largely due to rapid urbanization, which fosters the spread of infections by increasing population density and putting a strain on sanitation and healthcare infrastructure. IVD raw materials play a vital role in addressing infectious diseases by enabling the creation of accurate diagnostic tests for early detection and effective disease management. For example, a report published in May 2023 by the Statens Serum Institut, a medical laboratory based in Denmark, stated that in 2021, there were 146 cases of chronic hepatitis C, with 72% (105 cases) affecting men, and this number rose to 196 cases in 2022, with 67% (131 cases) involving men. Thus, the growing prevalence of infectious diseases is contributing to the expansion of the IVD raw materials market.

Companies in the IVD raw materials market are increasingly focusing on developing advanced solutions, such as IVD manufacturing facilities, to enhance regional diagnostic capabilities and promote healthcare self-sufficiency. An IVD manufacturing facility is a specialized place where diagnostic devices and equipment are designed, produced, and tested for quality and compliance. For instance, in January 2024, Colexa Biosensor Limited, a Nigeria-based health technology company, collaborated with Codix Pharma Limited, a Nigerian pharmaceutical manufacturer, to launch Sub-Saharan Africa’s first IVD manufacturing facility in Lagos. This facility, which produces the onpoint blood glucose meter and strips, represents a significant step forward for Africa’s healthcare sector, aimed at tackling the rising diabetes prevalence and improving access to diagnostics. The facility can produce 3.6 million packs annually, with plans to expand production to 10.8 million packs, focusing initially on West Africa’s needs.

In November 2022, Fapon Biotech Inc., a China-based life sciences company offering high-quality IVD raw materials, partnered with Roche Diagnostics to drive innovation and growth within China’s in vitro diagnostics industry. Through this collaboration, both companies aim to leverage their combined resources to develop and improve comprehensive solutions tailored to local needs, speed up research and development, and foster continuous innovation in the Chinese IVD industry. Roche Diagnostics, a Swiss pharmaceutical company, specializes in diagnostic tests, instruments, and digital solutions.

Major players in the ivd raw materials market are F. Hoffmann-La Roche, Merck KGaA, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company (BD), Agilent Technologies, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., and NOVA Biologics Inc.

North America was the largest region in the IVD raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in IVD raw materials report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the IVD raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

In vitro diagnostics (IVD) raw materials are the essential biological and chemical substances needed for the creation and development of diagnostic assays that analyze biological samples outside the human body. These materials help in the detection, measurement, or evaluation of analytes in clinical samples for diagnostic, screening, or monitoring purposes.

The primary products in IVD raw materials include antibodies, antigens, enzymes, proteins, biological buffers, and others. Antibodies in IVD raw materials are specialized proteins designed to detect and bind to specific antigens, facilitating the accurate identification of diseases or conditions in diagnostic tests. These materials are utilized in technologies such as molecular diagnostics, clinical chemistry, immunochemistry, and others, by end users including pharmaceutical and biotechnology companies, diagnostic laboratories, contract research organizations, and others.

The IVD raw materials market research report is one of a series of new reports that provides IVD raw materials market statistics, including IVD raw materials industry global market size, regional shares, competitors with a IVD raw materials market share, detailed IVD raw materials market segments, market trends and opportunities, and any further data you may need to thrive in the IVD raw materials industry. This IVD raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The IVD raw materials market consists of sales of protein stabilizers, phosphate-buffered saline, washing buffers, and chelating agents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.